Workout
Healthy Eating
Meditation
Podcast
Authenticity
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

The 6 clubs that are interested in signing Dani Olmo from Barcelona if he leaves for free

Barcelona are nervously hoping to find a way to sign Dani Olmo for the second half of the season, aware that once the deadline has passed, he has a clause in his contract that allows him to leave for free. His agent Andy Barça has stated that he will remain at Barcelona no matter what, but there is no shortage of clubs willing to discuss why he should change his mind.

According to Sport, in the Premier League alone, Manchester City, Arsenal and Chelsea are closely monitoring Olmo’s availability. Former Spain coach Luis Enrique will be more than familiar with his talent, and Paris Saint-Germain are also interested, as is Bayern Munich, one of the teams that showed interest in him during the summer. Perhaps the most intriguing of all is Atlético Madrid, who have made a lot of profit by signing former Barcelona players.

Olmo seems determined to remain in Barcelona and, until that changes, it remains a moot point. However, Olmo could make enormous profits from the operation if he signed for another club for free. Not only would he likely receive high wages and a high signing bonus, but he would also receive the full €48 million of his six-year contract with Barcelona.

Last reviewed on

Expert Q&A

Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview

FitToFar is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

BE THE FIRST TO KNOW

SUBSCRIBE TO GET LATEST FITNESS AND NUTRITION UPDATES!

We don’t spam! Read our privacy policy for more info.

The FitToFar News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.